Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Palantir developing data-mining tool to optimize COVID-19 vaccine distribution  

By Brian Buntz | October 26, 2020

Palantir

Image from Markus Spiske on Unsplash

Palantir Technologies (NYSE:PLTR), the controversial data-mining company, will assist the U.S. government in tracking the administration of COVID-19 vaccines.

The company is developing a tool to enhance the logistics of vaccines for the novel coronavirus.

Founded in 2003, Palantir has a long history of working with the federal government. The company’s software possibly played a role in the CIA’s identification and assassination of Osama bin Laden.

Palantir has expanded its healthcare involvement in recent years. In 2018, it signed a $7 million contract with the National Center for Advancing Translational Sciences. Earlier this year, the company began working with the U.S. Department of Health and Human Services (HHS) to analyze data related to the novel coronavirus in a program known as HHS Protect. Further, HHS awarded two contracts to Palantir, valued together at $25 million, to analyze COVID-19 data from government, healthcare providers and universities.

For its vaccine contract with the U.S. government, Palantir has created a software system known as Tiberius that could identify high-priority populations for receiving a COVID-19 vaccine, according to the Wall Street Journal.

HHS has stressed that the Tiberius program won’t have access to sensitive health information.

Officials anticipate that the Tiberius system can optimize the delivery of vaccines to facilities administering the vaccine.

The system draws its name from the middle name of James T. Kirk, the Star Trek captain.

Tell Us What You Think! Cancel reply

Related Articles Read More >

President Joe Biden
Biden to order analysis of pharma supply chain
5 takeaways from the latest White House COVID-19 response team briefing
Pfizer-BioNTech vaccine
Pfizer vaccine stable at standard freezer temps, effective with single dose
Biden
Why Big Tech is offering Biden help with COVID-19 vaccination

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards